I only received Woodcock's internal memo on compounding. The other 6 were not filled, because the original requestor rescinded the FOIA requests before they were filled.
STS, AMRN gave up because they found out they were paranoid about MRC or Nissen. All it was like JL said FDA just wants to make sure they give a broad label reviewed by a panel after the NVS/Democrats debacle. They withdrew because they might have felt we are going to get Anchor approval by 9/28, imo.
Market Data 
Markets 
AI
